Mongodb Inc vs uniQure N.V. Ordinary Shares — how do they compare? Mongodb Inc trades at $348.99 (market cap $28.70B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Mongodb Inc is far larger — about 19.8× uniQure N.V. Ordinary Shares's market cap, and Mongodb Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Mongodb Inc for 46 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| MDB | QURE | |
|---|---|---|
Market Cap | $28.70B | $1.45B |
Volume | 1,357,938 | 3,323,243 |
Sector | Technology | Health |
52-Week High | $472.29 | $70.59 |
52-Week Low | $225.95 | $9.03 |
Typical Hold Time | 46 Days | 0 Days |
Enterprise Value | $26.32B | $707.46M |
Signals from Pluang's Aura AI — not financial advice
MongoDB (MDB) trades at $373.07, down 2.16% today, amid a bullish technical setup with moving averages supportive and a neutral oscillator stance. The company reported a net loss of $129.07 million in 2025, but revenue grew to $2.01 billion, with a projected return to profitability in 2026. Recent Investor Day highlighted new AI product launches and raised long-term growth targets, though the unexpected CEO departure to Meta caused volatility.
The outlook is positive with strong analyst support (80% buy ratings) and a $456.76 consensus price target implying significant upside. Key risks include execution during leadership transition and high valuation multiples. Revenue growth acceleration and AI-driven product adoption present the primary investment opportunity, balanced against competitive and macroeconomic pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →